金吾财讯 | 中国中药(00570)发盈警，拖累股价表现，早盘低开3.9%，报1.97港元，盘前成交额730.08万港元。据公告显示，预期集团于2024年溢利净额同比下降90%-100%；及本期经调整溢利净额同比下降50%-60%。公告指，本期溢利净额下降主要由于：(i)集采降价、市场竞争加剧及药材成本偏高等多重因素影响中药配方颗粒业务销售规模及盈利水平；(ii)本期信用减值、商誉减值及厂房减值增加；及(iii)公司的部分附属公司补缴税款对集团本期溢利净额造成较大影响。经调整溢利净额为扣除以下各项影响后的溢利净额：(i)根据本期经营状况，计提商誉及厂房减值准备；及(ii)部分附属公司补缴税款。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.